Restarting Sertraline for Mixed Anxiety and Depression

Dosing and Titration

Starting with a lower dose of sertraline, such as 50 mg once daily, allows assessment for behavioral activation/agitation, which can occur early in SSRI treatment and is more common in anxiety disorders, as recommended by the American Academy of Child and Adolescent Psychiatry 1
The risk of initial adverse effects, such as nausea, anxiety, and agitation, is dose-related and can be minimized by starting at 50 mg, according to the American Academy of Child and Adolescent Psychiatry 2, 3
Dose adjustments should not occur at intervals less than 1 week, and for anxiety presentations, the dose can be increased in the smallest available increments at approximately 1-2 week intervals as tolerated, as suggested by the American Academy of Child and Adolescent Psychiatry 2, 3

Close monitoring is essential, particularly in the first weeks of treatment, to watch for suicidal thinking and behavior, especially in the first months and following dose adjustments, with an absolute risk of 1% vs 0.2% for placebo, as reported by the American Academy of Child and Adolescent Psychiatry 1, 4
Monitoring for behavioral activation/agitation, such as restlessness, insomnia, and impulsiveness, is crucial in the first 24-48 hours and first month of treatment, according to the American Academy of Child and Adolescent Psychiatry 1, 4
Sertraline is associated with discontinuation syndrome, and if the patient stops again, tapering over 10-14 days is recommended, as advised by the American Academy of Child and Adolescent Psychiatry 2, 3, 5

Sertraline has demonstrated efficacy for both depression and anxiety disorders, with 53-85% of patients classified as treatment responders in clinical trials for panic disorder and PTSD, as reported in Neuropsychopharmacology 6